Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Durus Life Sciences Insider Profile
4 Followers
Durus Life Sciences, Shareholder at Novanta, holds 1.69M shares in Novanta (Ticker: NOVT). Most recently, Durus Life Sciences ― shares of Novanta on ― for an estimated value of ―.
Durus Life Sciences has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Durus Life Sciences's holdings
Insider Roles
Shareholder
Roles that Durus Life Sciences holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Durus Life Sciences
Durus Life Sciences's Trading History
List of latest transactions for each holding click on a transaction to see Durus Life Sciences's performance on stock
You May Also Like
Durus Life Sciences insider profile FAQ
What is the percentage of profitable transactions made by Durus Life Sciences?
The percentage of profitable transactions made by Durus Life Sciences is ―.
What is the average return per transaction made by Durus Life Sciences?
The average return per transaction made by Durus Life Sciences is ―.
What stocks does Durus Life Sciences hold?
Durus Life Sciences holds: NOVT stocks.
What was Durus Life Sciences’s latest transaction?
Durus Life Sciences latest transaction was an Uninformative Buy of ―.
What was Durus Life Sciences's most profitable transaction?
Durus Life Sciences’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Durus Life Sciences's role in Novanta?
Durus Life Sciences's role in Novanta is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.